Europe/India/Near East USA Asia
Bachem AG Bachem Americas, Inc. Bachem Japan K.K.
Hauptstrasse 144 3132 Kashiwa Street AREA Shinagawa, 13F
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA Tokyo 108-0075 - Japan
Tel +41 58 595 2021 Tel +1 888 422 2436 Tel +81 3 4405 3141
Fax +41 58 595 2040 Tel +1 888 4BACHEM Email
Email Fax +1 310 539 9428  



Clinalfa® is Bachem’s brand name for sterile peptides. Clinalfa® products are manufactured and released by Bachem Distribution Services GmbH, Weil am Rhein, Germany. 

The following Clinalfa® product lines are available from Bachem:

Clinalfa® basic
products are sterile freeze-dried peptides readily available from stock. The supply of Clinalfa® basic peptides is accompanied by Bachem’s Certificate of Analysis (CofA) signed by Bachem’s Qualified Person (QP).

Clinalfa® plus products are sterile freeze-dried or ready-to-use liquid formulations made according to customer requirements. In many cases, the active pharmaceutical ingredients (APIs) and the resulting Clinalfa® products are proprietary products of Bachem’s customers. Based on agreements between the customer and Bachem, Bachem’s Qualified Person (QP) may release the products for use in a specific clinical study approved by the competent authority, and also for market approval.

Clinalfa® Services

Bachem offers related services to Clinalfa® basic and Clinalfa® plus products, i.e. formulation development, compatibility studies, stress test and post-release stability studies, CMC-documentation for IMPD and IND, drug master file and other services.